Edge Therapeutics

After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
Xconomy
Mon, 11/26/18 - 10:04 am
Edge Therapeutics
head injury
clinical trials
M&A
PDS Biotechnology
immuno-oncology
Edge Therapeutics hauls in $72.5M for brain injury R&D
Fierce Biotech
Thu, 04/9/15 - 03:10 pm
Edge Therapeutics
R&D
EG-1962
aneurysms
brain injury
SurModics and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product
Fri, 11/5/10 - 12:05 pm
SurModics
Edge Therapeutics
NimoGel
EG-1961
cerebral ischemia
subarachnoid hemorrhage